Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Genomic Health Inc (NASDAQ:GHDX)

29.83
Delayed Data
As of Feb 24
 +0.30 / +1.02%
Today’s Change
22.00
Today|||52-Week Range
33.96
+1.50%
Year-to-Date
3 Most Wildly Overvalued Stocks in Healthcare
Feb 23 / MotleyFool.com - Paid Partner Content
Genomic Health, Inc. Swings to a Profit
Feb 15 / MotleyFool.com - Paid Partner Content
Why Genomic Health Inc. Jumped Higher Today
Feb 15 / MotleyFool.com - Paid Partner Content
Genomic Health (GHDX) Earnings Surpass Estimates in Q4
Feb 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close29.53
Today’s open29.22
Day’s range29.15 - 29.90
Volume119,212
Average volume (3 months)157,757
Market cap$998.7M
Dividend yield--
Data as of 4:14pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+59.22%
Earnings growth (this year)+107.56%
Earnings growth (next 5 years)-620.03%
Revenue growth (last year)+14.06%
P/E ratioNM
Price/Sales2.98
Price/Book--

Competitors

 Today’s
change
Today’s
% change
KANGiKang Healthcare Gro...-0.27-1.58%
FMIFoundation Medicine ...-0.15-0.65%
NEONeogenomics Inc+0.03+0.37%
NTRANatera Inc-0.04-0.41%
Data as of 3:59pm ET, 02/24/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$327.9M
Annual profit (last year)-$13.9M
Net profit margin-4.25%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Kimberly J. Popovits
Chief Operating &
Financial Officer
G. Bradley Cole
Corporate headquarters
Redwood City, California

Forecasts


Search for Jobs